On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.
“We can’t take the orphan drug revolution for granted.“ Biorasi’s Few & Far Between Podcast welcomes Jim Geraghty, author and biotech industry veteran, to...
"And what I was really surprised about was that everybody was doing data collection in a different way. And I kept thinking that, gosh,...
How do today’s CEOs and founders find the balance between planning and entrepreneurship? Check out the latest episode of the Biorasi Few & Far...